Interactions between Neisseria meningitidis and the complement system

Yazdankhah, 2004, Neisseria meningitidis: an overview of the carriage state, J. Med. Microbiol., 53, 821, 10.1099/jmm.0.45529-0 Tzeng, 2000, Epidemiology and pathogenesis of Neisseria meningitidis, Microbes Infect., 2, 687, 10.1016/S1286-4579(00)00356-7 van Deuren, 2000, Update on meningococcal disease with emphasis on pathogenesis and clinical management, Clin. Microbiol. Rev., 13, 144, 10.1128/CMR.13.1.144-166.2000 Morgan, 1991, Complement deficiency and disease, Immunol. Today, 12, 301, 10.1016/0167-5699(91)90003-C Borrow, 2005, Meningococcal surrogates of protection–serum bactericidal antibody activity, Vaccine, 23, 2222, 10.1016/j.vaccine.2005.01.051 Lehmann, 1997, Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis, J. Immunol. Methods, 200, 55, 10.1016/S0022-1759(96)00185-8 West, 2005, Optimization of virulence functions through glucosylation of Shigella LPS, Science, 307, 1313, 10.1126/science.1108472 Vogel, 1999, Mechanisms of neisserial serum resistance, Mol. Microbiol., 32, 1133, 10.1046/j.1365-2958.1999.01469.x Morgan, 2005, Complement: central to innate immunity and bridging to adaptive responses, Immunol. Lett., 97, 171, 10.1016/j.imlet.2004.11.010 Hazelzet, 1998, Complement activation in relation to capillary leakage in children with septic shock and purpura, Infect. Immun., 66, 5350, 10.1128/IAI.66.11.5350-5356.1998 Fujita, 2004, The lectin-complement pathway – its role in innate immunity and evolution, Immunol. Rev., 198, 185, 10.1111/j.0105-2896.2004.0123.x Ehlenberger, 1977, The role of membrane receptors for C3b and C3d in phagocytosis, J. Exp. Med., 145, 357, 10.1084/jem.145.2.357 Figueroa, 1993, Complement deficiency states and meningococcal disease, Immunol. Res., 12, 295, 10.1007/BF02918259 Milis, 1993, Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9, Clin. Exp. Immunol., 92, 114, 10.1111/j.1365-2249.1993.tb05956.x Tschopp, 1993, Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8β, and the B domain of C9, J. Immunol., 151, 2159, 10.4049/jimmunol.151.4.2159 Inal, 2005, Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor, J. Immunol., 174, 356, 10.4049/jimmunol.174.1.356 Fine, 1983, Meningococcal meningitis in a women with inherited deficiency of the ninth component of complement, Clin. Immunol. Immunopathol., 28, 413, 10.1016/0090-1229(83)90108-3 Rosa, 2004, Deficiency of the eighth component of complement associated with recurrent meningococcal meningitis: case report and literature review, Braz. J. Infect. Dis., 8, 328, 10.1590/S1413-86702004000400010 Lehner, 1992, Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release, Lancet, 340, 1379, 10.1016/0140-6736(92)92561-S Bax, 1999, Association of familial deficiency of mannose-binding lectin and meningococcal disease, Lancet, 354, 1094, 10.1016/S0140-6736(99)02563-5 Brandtzaeg, 1992, Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy, J. Clin. Invest., 89, 816, 10.1172/JCI115660 Sprong, 2006, Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections, Blood, 107, 4865, 10.1182/blood-2005-07-2820 Fijen, 1989, Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups, Lancet, 2, 585, 10.1016/S0140-6736(89)90712-5 Nielsen, 1989, Complement deficiencies in selected groups of patients with meningococcal disease, Scand. J. Infect. Dis., 21, 389, 10.3109/00365548909167442 Hibberd, 1999, Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease, Lancet, 353, 1049, 10.1016/S0140-6736(98)08350-0 Kuipers, 2003, A case of familial meningococcal disease due to deficiency in mannose-binding lectin (MBL), Adv. Exp. Med. Biol., 531, 351, 10.1007/978-1-4615-0059-9_29 Tully, 2006, Risk and protective factors for meningococcal disease in adolescents: matched cohort study, BMJ, 332, 445, 10.1136/bmj.38725.728472.BE Jack, 2005, Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages, J. Leukoc. Biol., 77, 328, 10.1189/jlb.0604342 Estabrook, 2004, Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis, J. Immunol., 172, 3784, 10.4049/jimmunol.172.6.3784 Jack, 2001, Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B, J. Infect. Dis., 184, 1152, 10.1086/323803 Sprong, 2004, Mannose binding lectin enhances IL-1β and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis, Cytokine, 28, 59, 10.1016/j.cyto.2004.06.007 Haralambous, 2006, Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients, Scand. J. Infect. Dis., 38, 764, 10.1080/00365540600643203 Duthy, 2002, The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15, Infect. Immun., 70, 5604, 10.1128/IAI.70.10.5604-5611.2002 Hellwage, 2001, The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi, J. Biol. Chem., 276, 8427, 10.1074/jbc.M007994200 Ram, 1998, Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae, J. Exp. Med., 188, 671, 10.1084/jem.188.4.671 Ram, 1998, A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae, J. Exp. Med., 187, 743, 10.1084/jem.187.5.743 Wei, 2005, Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes, Infect. Immun., 73, 2040, 10.1128/IAI.73.4.2040-2050.2005 Klein, 2005, Complement factor H polymorphism in age-related macular degeneration, Science, 308, 385, 10.1126/science.1109557 Saunders, 2006, An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations, Hum. Mutat., 27, 21, 10.1002/humu.20268 Jones, 1992, The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis, Microb. Pathog., 13, 219, 10.1016/0882-4010(92)90022-G Geoffroy, 2003, Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis, Genome Res., 13, 391, 10.1101/gr.664303 Kwara, 1998, Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa, Trop. Med. Int. Health, 3, 742, 10.1046/j.1365-3156.1998.00300.x Wilder-Smith, 2003, Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers, Clin. Infect. Dis., 36, 679, 10.1086/367858 Pollard, 2001, Meningococcal disease and vaccination in North America, J. Paediatr. Child Health, 37, S20, 10.1046/j.1440-1754.2001.00679.x Kahler, 1998, The (α2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum, Infect. Immun., 66, 5939, 10.1128/IAI.66.12.5939-5947.1998 World Health Organization, Geneva, 2005, Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience, Wkly. Epidemiol. Rec., 80, 313 Vogel, 1996, Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat, Med. Microbiol. Immunol., 185, 81, 10.1007/s004300050018 Vogel, 1997, Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis, Infect. Immun., 65, 4022, 10.1128/IAI.65.10.4022-4029.1997 Vogel, 1999, Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates, Infect. Immun., 67, 954, 10.1128/IAI.67.2.954-957.1999 Pavliak, 1993, Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis, J. Biol. Chem., 268, 14146, 10.1016/S0021-9258(19)85220-1 Estabrook, 1997, Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose, Infect. Immun., 65, 4436, 10.1128/IAI.65.11.4436-4444.1997 Vogel, 1997, Functional characterization of an isogenic meningococcal α-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci, Med. Microbiol. Immunol., 186, 159, 10.1007/s004300050059 Ram, 2003, Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity, J. Biol. Chem., 278, 50853, 10.1074/jbc.M308364200 Bishof, 1990, C4B deficiency: a risk factor for bacteremia with encapsulated organisms, J. Infect. Dis., 162, 248, 10.1093/infdis/162.1.248 Smith, 2001, Lactate stimulation of gonococcal metabolism in media containing glucose: mechanism, impact on pathogenicity, and wider implications for other pathogens, Infect. Immun., 69, 6565, 10.1128/IAI.69.11.6565-6572.2001 Exley, 2005, Available carbon source influences the resistance of Neisseria meningitidis against complement, J. Exp. Med., 201, 1637, 10.1084/jem.20041548 Post, 2005, Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B, J. Biol. Chem., 280, 38383, 10.1074/jbc.M508063200 Sprong, 2004, Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide, Infect. Immun., 72, 3344, 10.1128/IAI.72.6.3344-3349.2004 Claus, 2004, Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci, Mol. Microbiol., 51, 227, 10.1046/j.1365-2958.2003.03819.x Jarva, 2005, Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis, J. Immunol., 174, 6299, 10.4049/jimmunol.174.10.6299 Blom, 2004, Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?, Mol. Immunol., 40, 1333, 10.1016/j.molimm.2003.12.002 Hillarp, 1988, Novel subunit in C4b-binding protein required for protein S binding, J. Biol. Chem., 263, 12759, 10.1016/S0021-9258(18)37818-9 Ram, 2001, Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae, J. Exp. Med., 193, 281, 10.1084/jem.193.3.281 Blom, 2004, Strategies developed by bacteria and virus for protection from the human complement system, Scand. J. Clin. Lab. Invest., 64, 479, 10.1080/00365510410002904 Zipfel, 2002, Factor H family proteins: on complement, microbes and human diseases, Biochem. Soc. Trans., 30, 971, 10.1042/bst0300971 Schneider, 2006, Functional significance of factor H binding to Neisseria meningitidis, J. Immunol., 176, 7566, 10.4049/jimmunol.176.12.7566 Madico, 2006, The meningococcal vaccine candidate GNA1870 binds the complement Regulatory protein factor H and enhances serum resistance, J. Immunol., 177, 501, 10.4049/jimmunol.177.1.501 Masignani, 2003, Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870, J. Exp. Med., 197, 789, 10.1084/jem.20021911 Hogasen, 1994, Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin–thrombin–antithrombin complex, Infect. Immun., 62, 4874, 10.1128/IAI.62.11.4874-4880.1994 Kallstrom, 1997, Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria, Mol. Microbiol., 25, 639, 10.1046/j.1365-2958.1997.4841857.x Johansson, 2003, CD46 in meningococcal disease, Science, 301, 373, 10.1126/science.1086476 Sprong, 2003, Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis, Blood, 102, 3702, 10.1182/blood-2003-03-0703 Goldschneider, 1969, Human immunity to the meningococcus. I. The role of humoral antibodies, J. Exp. Med., 129, 1307, 10.1084/jem.129.6.1307 Edwards, 2001, The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia, Cell. Microbiol., 3, 611, 10.1046/j.1462-5822.2001.00140.x